antibodies react antigens surface tumor cells normal cells great potential cancer detection therapy radiolabeled loss immunologic specificity antibodies able deliver cytoxic amounts radiation specificity high extraction coefficient necessary radionuclide order minimize normal tissue irradiation time rate catabolized radionuclide influence ultimate applicability unanswered questions choosing radionuclide choice particle emitter classic beta emitters used number clinical situations major impact disease outcome diseases thyroid unfortunately auger emitters iodine NUMBER cytotoxic localized close proximity genome hand alpha emitters astatine NUMBER eliminate need subcellular sequestration localization references NUMBER target cell tumor cell retention cell specific